FDA Grants Bright Path AMT Designation as It Moves to Reshore America's Medicines and Reduce Reliance on China
/PRNewswire/ -- Bright Path, a U.S. pharmaceutical manufacturer, today announced that the U.S. Food and Drug Administration (FDA) has granted the company an...